Pacer Advisors Inc. raised its position in Waters Co. (NYSE:WAT) by 16.5% during the second quarter, according to the company in its most recent 13F filing with the Securities and Exchange Commission. The fund owned 7,969 shares of the medical instruments supplier’s stock after purchasing an additional 1,126 shares during the period. Pacer Advisors Inc.’s holdings in Waters were worth $1,715,000 as of its most recent filing with the Securities and Exchange Commission.
Several other institutional investors and hedge funds have also recently made changes to their positions in the company. Thor Advisors LLC purchased a new position in Waters in the first quarter valued at $64,000. Amica Retiree Medical Trust acquired a new position in shares of Waters during the 2nd quarter worth about $69,000. ETF Managers Group LLC boosted its position in shares of Waters by 10.6% during the 1st quarter. ETF Managers Group LLC now owns 721 shares of the medical instruments supplier’s stock worth $181,000 after acquiring an additional 69 shares in the last quarter. Livforsakringsbolaget Skandia Omsesidigt increased its holdings in shares of Waters by 46.1% in the 2nd quarter. Livforsakringsbolaget Skandia Omsesidigt now owns 951 shares of the medical instruments supplier’s stock valued at $205,000 after acquiring an additional 300 shares during the last quarter. Finally, Greenleaf Trust purchased a new position in shares of Waters in the 1st quarter valued at about $211,000. Institutional investors and hedge funds own 95.08% of the company’s stock.
WAT has been the subject of several recent analyst reports. Zacks Investment Research upgraded Waters from a “sell” rating to a “hold” rating and set a $217.00 target price for the company in a research note on Wednesday, May 22nd. Wolfe Research initiated coverage on shares of Waters in a research note on Thursday, May 30th. They issued an “underperform” rating on the stock. ValuEngine cut shares of Waters from a “buy” rating to a “hold” rating in a report on Thursday, August 1st. Cleveland Research downgraded shares of Waters from a “neutral” rating to an “underperform” rating in a research report on Wednesday, June 12th. Finally, Bank of America downgraded shares of Waters from a “neutral” rating to an “underperform” rating in a research report on Tuesday, July 16th. Five investment analysts have rated the stock with a sell rating, eight have given a hold rating and one has given a buy rating to the company’s stock. The company currently has a consensus rating of “Hold” and a consensus price target of $210.54.
Waters (NYSE:WAT) last released its quarterly earnings data on Tuesday, July 30th. The medical instruments supplier reported $2.14 earnings per share for the quarter, beating the consensus estimate of $2.11 by $0.03. The firm had revenue of $599.20 million during the quarter, compared to the consensus estimate of $601.46 million. Waters had a return on equity of 50.64% and a net margin of 24.09%. Waters’s quarterly revenue was up .5% on a year-over-year basis. During the same period last year, the business posted $1.95 EPS. Research analysts forecast that Waters Co. will post 9.01 EPS for the current fiscal year.
Waters Company Profile
Waters Corporation, a specialty measurement company, provides analytical workflow solutions in Asia, the Americas, and Europe. It operates through two segments, Waters and TA. The company designs, manufactures, sells, and services high and ultra-performance liquid chromatography, as well as mass spectrometry (MS) technology systems and support products, including chromatography columns, other consumable products, and post-warranty service plans.
See Also: What is a stock buyback?
Receive News & Ratings for Waters Daily - Enter your email address below to receive a concise daily summary of the latest news and analysts' ratings for Waters and related companies with MarketBeat.com's FREE daily email newsletter.